ABAVITE

Manufacturer
ABACOS HEALTH
Effective date
2021-10-06
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 22:33:32

Label at a glance#

ProductABAVITE
Active ingredientMETHYLCOBALAMIN, ASCORBIC ACID, NIACIN, MAGNESIUM OXIDE, VITAMIN A PALMITATE, ZINC OXIDE, .ALPHA.-TOCOPHEROL ACETATE, DL-, FOLIC ACID, THIAMINE MONONITRATE, CHOLECALCIFEROL, FERROUS SULFATE, CALCIUM PANTOTHENATE, POTASSIUM IODIDE, RIBOFLAVIN
Label structure9 sections

Storage and handling

The usual adult dose is 1 tablet once or twice daily or as instructed by a licensed medical practitioner. If you are pregnant or nursing, ask a healthcare professional

Label contents#

Full prescribing information#

COMPONENTS

]

Name of Ingredient

Amount per serving

% Daily Value

Vitamin A (Palmitate [1100IU]

330 mcg

37%

Vitamin C (as ascorbic acid)

60 mg

67%

Vitamin D (as cholecalciferol [400IU])

25 mcg

125%

Vitamin E (as dl-alpha tocopheryl acetate [30IU])

13.5 mg

90%

Thiamine (vitamin B1) (as thiamine mononitrate)

1.6 mg

133%

Riboflavin (vitamin B2)

1.8 mg

138%

Niacin (as niacinamide)

15 mg

94%

Vitamin B6 (as pyridoxine hydrochloride)

10 mg

588%

Folate

1667 mcg DFE

(1000 mcg folic acid)

417%

Vitamin B12 (as methylcobalamin)

500 mcg

20833%

Pantothenic acid (as d-calcium pantothenate)

5 mg

100%

Iron (as ferrous sulfate)

30 mg

167%

Iodine (as potassium iodide)

250 mcg

167%

Magnesium (as magnesium oxide)

25 mg

6%

Zinc (as zinc oxide)

15 mg

136%

Other inactive Ingredients:

Other Ingredients: Microcrystalline Cellulose, Croscarmellose Sodium, Stearic Acid, SodiumCitrate, Silicon Dioxide, Magnesium Stearate, Clear Vegetable Coating: Hypromellose, Glycerine

INDICATIONS & USAGE SECTION

ABAVITE is a supplement indicated to provide vitamin, mineral supplementation to support optimum vitamin levels.

DOSAGE & ADMINISTRATION SECTION

The usual adult dose is 1 tablet once or twice daily or as instructed by a licensed medical practitioner. If you are pregnant or nursing,ask a healthcare professional Dosage abd AdministrationDosage abd Administration

WARNINGS SECTION

Vitamin D therapy should be cautiously used in patients with hyperparathyroidism (or any condition which may lead directly or indirectly to hypercalcemia), hypercalcemia, or people who have renal stones or at risk of having renal stones. High doses of vitamin D may elevate levels of calcium, which may eventually accumulate in the blood and soft tissues. Bone pain, high blood pressure, the formation of kidney stones, renal failure, and increased risk of heart disease can also occur.

Prolonged use of iron supplements may lead to iron storage disease.

WARNING: Accidental overdose of iron containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

High Dose Folic acid supplementation may conceal an occult vitamin B 12 deficiency and further exacerbate or initiate neurologic disease. Therefore, clinicians should consider ruling out vitamin B 12 deficiency before initiating folic acid therapy.

Do NOT use Abavite if you have an allergy for one or more components listed above.

Possible interactions:

High doses of folic acid may result in reduced serum levels of anticonvulsant drugs.

Vitamin D supplementation should be avoided in hypercalcemia or conditions that may lead to hypercalcemia such as hyperparathyroidism and those who form calcium-containing kidney stones (Calcium oxalate stones).

Consult your physician or pharmacist for additional information regarding vitamin-drug interactions.

CONTRAINDICATIONS SECTION

ABAVITE is Contraindicated in patients with known or documented hypersensitivity to any of its listed ingredients or color additives. Folic acid is a contraindication in patients with untreated and uncomplicated pernicious anemia and those with an anaphylactic allergy to folic acid. Iron therapy is a contraindication in patients with hemochromatosis or Potential or current disease, which involves iron storage due to chronic hemolytic anemia (e.g., inherited anomalies of hemoglobin structure or synthesis), red cell enzyme deficiencies, etc.); pyridoxine responsive anemia, or cirrhosis of the liver. Methylcobalamin is a contraindication in patients with sensitivity to cobalt or methylcobalamin (Vitamin B-12).

PREGNANCY SECTION

If you're pregnant or nursing mother you should ask your healthcare practitioner before use.

PEDIATRIC USE SECTION

Not for pediatric use. Keep out of reach of Children

STORAGE AND HANDLING SECTION

The usual adult dose is 1 tablet once or twice daily or as instructed by a licensed medical practitioner. If you are pregnant or nursing,
ask a healthcare professional

Prencible Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Prencible Display PanelPrencible Display Panel

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 32 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
73397-31173397-311-30

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 22 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
cefaa207-18ff-fc64-e053-2a95a90acc95adce9efb-0a39-80ec-e053-2995a90a53bb2021-10-22WarningsExact identifier
spl set id: adce9efb-0a39-80ec-e053-2995a90a53bb

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.